Literature DB >> 2597837

Circumstances surrounding the initial lapse to opiate use following detoxification.

B P Bradley1, G Phillips, L Green, M Gossop.   

Abstract

Seventy-eight opiate abusers were followed up after successful in-patient detoxification in order to examine renewed opiate use. The greatest number of initial lapses occurred within a week of subjects leaving in-patient treatment. Eleven categories of lapse precipitant were identified: cognitive, mood, external, withdrawal, interpersonal, leaving a protected environment, drug availability, drug-related cues, craving, priming, and social pressure. Cognitions, negative moods and external events emerged as the most commonly mentioned factors; these often occurred together, either in clusters or in a sequence. Implications of these results for models of relapse and for treatment approaches are discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2597837     DOI: 10.1192/bjp.154.3.354

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  17 in total

1.  Mindfulness-based treatments for co-occurring depression and substance use disorders: what can we learn from the brain?

Authors:  Judson A Brewer; Sarah Bowen; Joseph T Smith; G Alan Marlatt; Marc N Potenza
Journal:  Addiction       Date:  2010-10       Impact factor: 6.526

Review 2.  The neurobiology and genetics of impulse control disorders: relationships to drug addictions.

Authors:  Judson A Brewer; Marc N Potenza
Journal:  Biochem Pharmacol       Date:  2007-07-03       Impact factor: 5.858

Review 3.  Acupuncture-related techniques for the treatment of opiate addiction: a case of translational medicine.

Authors:  Jisheng Han; Cailian Cui; Liuzhen Wu
Journal:  Front Med       Date:  2011-06-22       Impact factor: 4.592

4.  Differential vulnerability to relapse into heroin versus cocaine-seeking as a function of setting.

Authors:  Christian Montanari; Emiliana Stendardo; Maria Teresa De Luca; Maria Meringolo; Laura Contu; Aldo Badiani
Journal:  Psychopharmacology (Berl)       Date:  2015-02-10       Impact factor: 4.530

5.  Clonidine Increases the Likelihood That Abstinence Can Withstand Unstructured Time in Buprenorphine-maintained Outpatients.

Authors:  William J Kowalczyk; Jeremiah W Bertz; Landhing M Moran; Karran A Phillips; Udi E Ghitza; David H Epstein; Kenzie L Preston
Journal:  J Addict Med       Date:  2017 Nov/Dec       Impact factor: 3.702

6.  Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals.

Authors:  Mark K Greenwald; Leslie H Lundahl; Caren L Steinmiller
Journal:  Psychopharmacology (Berl)       Date:  2012-11-17       Impact factor: 4.530

7.  Early outcomes following low dose naltrexone enhancement of opioid detoxification.

Authors:  Paolo Mannelli; Ashwin A Patkar; Kathleen Peindl; Edward Gottheil; Li-Tzy Wu; David A Gorelick
Journal:  Am J Addict       Date:  2009 Mar-Apr

8.  A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification.

Authors:  Christina S Meade; Scott E Lukas; Leah J McDonald; Garrett M Fitzmaurice; Jessica A Eldridge; Nancy Merrill; Roger D Weiss
Journal:  J Subst Abuse Treat       Date:  2009-07-01

9.  Stress and drug-cue-induced craving in opioid-dependent individuals in naltrexone treatment.

Authors:  Scott M Hyman; Helen Fox; Kwang-Ik A Hong; Cheryl Doebrick; Rajita Sinha
Journal:  Exp Clin Psychopharmacol       Date:  2007-04       Impact factor: 3.157

Review 10.  Modeling stress and drug craving in the laboratory: implications for addiction treatment development.

Authors:  Rajita Sinha
Journal:  Addict Biol       Date:  2008-10-20       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.